China Tian Yuan Healthcare Group Limited (HKG:0557)
0.5050
-0.0050 (-0.98%)
Sep 7, 2026, 2:24 PM HKT
HKG:0557 Revenue
China Tian Yuan Healthcare Group had revenue of 20.05M HKD in the half year ending June 30, 2026, with 34.90% growth. This brings the company's revenue in the last twelve months to 30.79M, up 50.78% year-over-year. In the year 2025, China Tian Yuan Healthcare Group had annual revenue of 19.18M, down -28.56%.
Revenue (ttm)
30.79M
Revenue Growth
+50.78%
P/S Ratio
6.54
Revenue / Employee
933.00K
Employees
33
Market Cap
201.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.18M | -7.67M | -28.56% |
| Dec 31, 2024 | 26.85M | -18.39M | -40.65% |
| Dec 31, 2023 | 45.23M | -8.99M | -16.57% |
| Dec 31, 2022 | 54.22M | -40.37M | -42.68% |
| Dec 31, 2021 | 94.59M | 38.25M | 67.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emperor Capital Group | 493.10M |
| China Art Financial Holdings | 475.43M |
| Dingyi Group Investment | 331.12M |
| Guangdong Join-Share Financing Guarantee Investment | 323.41M |
| Shandong Baogai New Materials Technology | 159.85M |
| Zuoli Kechuang Company | 137.15M |
| China Financial Services Holdings | 126.45M |
| WLS Holdings | 98.56M |